
Repatha: Uses, Dosage, Side Effects & Warnings - Drugs.com
Nov 13, 2025 · Repatha is used to lower high cholesterol alongside dietary changes and to reduce the risk of major cardiovascular events in those at increased risk for these events, such …
Repatha Patient Tips: 7 things you should know - Drugs.com
Sep 24, 2025 · Easy-to-read patient tips for Repatha covering how it works, benefits, risks, and best practices.
How does Repatha work? - Drugs.com
Feb 5, 2025 · Repatha is used to prevent heart attacks, strokes and the need for coronary revascularization in those with existing cardiovascular disease. It is also used to reduce low …
Evolocumab: Uses, Dosage, Side Effects, Warnings - Drugs.com
Aug 28, 2025 · Evolocumab is used to reduce the risk of major adverse cardiovascular events (MACE) in adults at increased risk for these events, and to reduce low-density lipoprotein …
Repatha Side Effects: Common, Severe, Long Term - Drugs.com
Jan 6, 2025 · Learn about the side effects of Repatha (evolocumab), from common to rare, for consumers and healthcare professionals.
Repatha Dosage Guide - Drugs.com
Aug 21, 2025 · Detailed dosage guidelines and administration information for Repatha (evolocumab). Includes dose adjustments, warnings and precautions.
How long should you take Repatha? - Drugs.com
Sep 19, 2024 · Why do you need to take Repatha (evolocumab) long term? Repatha is a medicine that is designed to be taken long term to reduce the risk of cardiovascular disease. …
Evolocumab Monograph for Professionals - Drugs.com
Mar 10, 2025 · Evolocumab reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).
Repatha FAQ Answered by Healthcare Professionals
Mar 8, 2025 · Commonly asked questions concerning Repatha, answered by the Drugs.com team of qualified healthcare professionals.
How fast does Repatha work? - Drugs.com
Sep 19, 2024 · How fast does Repatha reduce the risk of cardiovascular events? In the first year on Repatha in the Fourier Clinical trial, there was a 12% risk reduction in the group of …